Mayo Clinic and Exact Sciences Corp.
Vijay Shah, M.D., chair, Department of Gastroenterology and Hepatology, Mayo Clinic
David Ahlquist, M.D., Department of Gastroenterology and Hepatology, Mayo Clinic
Kevin Conroy, chief executive officer, Exact Sciences
Audio news conference about Cologuard, a stool DNA test for colorectal cancer screening.
Monday, Aug. 25, 10 a.m. CT, 11 a.m. ET
Journalists can join the call at: 800-763-5545
Exact Sciences Corp. (NASDAQ: EXAS) is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. Mayo Clinic is a nonprofit worldwide leader in medical care, research and education.
MEDIA CONTACT: Brian Kilen, Mayo Clinic Public Affairs, 507-284-5005, email@example.com